Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryan Bott
Observed name:
Bott, Ryan
Institution:
University of Illinois Chicago
Observed institution:
University of Illinois Chicago
ORCID:
0009-0004-2086-0304
Observed ORCID:
0009-0004-2086-0304
OpenAlex ID:
A5036756577
Synthesis, Optimization, and Structure–Activity Relationships of Imidazo[1,2-a]pyrimidines as Inhibitors of Group 2 Influenza A Viruses
2022
·
Saad Alqarni
, Laura Cooper
, et al.
·
Journal of Medicinal Chemistry
·
31
Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses
2025
·
Malaika D. Argade
, Varada Anirudhan
, et al.
·
European Journal of Medicinal Chemistry
·
13
N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors
2024
·
Destiny Durante
, Ryan Bott
, et al.
·
Journal of Medicinal Chemistry
·
12
PDF
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses
2024
·
Malaika D. Argade
, Jazmin Galván Achi
, et al.
·
Journal of Medicinal Chemistry
·
8
PDF
Recombinant Pichinde reporter virus as a safe and suitable surrogate for high-throughput antiviral screening against highly pathogenic arenaviruses
2025
·
Carolina Q. Sacramento
, Ryan Bott
, et al.
·
Antiviral Research
·
6
Dihydroorotate dehydrogenase inhibitors are potent antiviral agents against henipaviruses and arenaviruses
2026
·
Yuanyuan Li
, Jing Ma
, et al.
·
Antiviral Research
·
1
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of Henipaviruses
2026
·
Irina N. Gaisina
, Malaika D. Argade
, et al.
·
Journal of Medicinal Chemistry
·
1
Discovery and Structure–Activity Relationship Studies of Thienopyrroles as Group 2 Influenza A Entry Inhibitors
2026
·
John P. Sloan
, Ryan Bott
, et al.
·
ACS Medicinal Chemistry Letters
PDF
Configurationally Locked Ridaifen-B Analogs as Potent Ebola Virus Entry Inhibitors
2026
·
Shaimaa M. Aboukhatwa
, Carolina Q. Sacramento
, et al.
·
Journal of Medicinal Chemistry
Discovery and Characterization of 7,8-Dihydropyrido[4,3-d]pyrimidines as SARS-CoV-2 Entry Inhibitors
2025
·
Sean P. Bradley
, Jazmin M. Galván Achi
, et al.
·
Drugs and Drug Candidates
PDF
Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679]
2025
·
Malaika D. Argade
, Varada Anirudhan
, et al.
·
European Journal of Medicinal Chemistry
CCDC 2156558: Experimental Crystal Structure Determination
2022
·
Alqarni, Saad
, Cooper, Laura
, et al.
·
The Cambridge Structural Database
Show more works
View as search
Works count:
12
Citation count:
72
H-index:
5
I10-index:
3
Year
Topic
Type